<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Bluejay Reports FDA Agrees to Consider its Plan to Pursue a De Novo Regulatory Pathway for the Symphony IL-6 Test	</title>
	<atom:link href="https://bluejaydx.com/2022/06/09/bluejay-reports-fda-agrees-to-consider-its-plan-to-pursue-a-de-novo-regulatory-pathway-for-the-symphony-il-6-test/feed/" rel="self" type="application/rss+xml" />
	<link>https://bluejaydx.com/2022/06/09/bluejay-reports-fda-agrees-to-consider-its-plan-to-pursue-a-de-novo-regulatory-pathway-for-the-symphony-il-6-test/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=bluejay-reports-fda-agrees-to-consider-its-plan-to-pursue-a-de-novo-regulatory-pathway-for-the-symphony-il-6-test</link>
	<description>A Clinical Stage Diagnostic Company</description>
	<lastBuildDate>Thu, 09 Jun 2022 12:41:56 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=5.9.13</generator>
</channel>
</rss>
